Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Zollinger-Ellison Syndrome 1Vomiting 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Neoplasms 1Ototoxicity 1Osteosarcoma 1Neoplasm Metastasis 1Gastrinoma 1Duodenal Neoplasms 1Breast Neoplasms 1

Interventions

obeticholic acid 1fludarabine 1apixaban 1aldesleukin 1X-Rays 1Tea 1Surgical Procedures, Operative 1Specimen Handling 1Rivaroxaban 1Phantoms, Imaging 1Pantoprazole 1Iopamidol 1Hydromorphone 1High-Energy Shock Waves 1Endoscopy, Gastrointestinal 1Dalteparin 1Cyclophosphamide 1Bupivacaine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Duodenal Neoplasms × Pantoprazole × Clear all
NCT05251233 2025-05-06

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Washington University School of Medicine

Phase 2 Terminated
56 enrolled 11 charts
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡